PRRT2 and adenocarcinoma: Although an inhibitory effect of RES on PKC has been reported in adenocarcinoma cells [93], we show for the first time that RES has a biphasic concentration effect on PKC activation in normal human endothelial cells and demonstrated the implication of ROS in its mediation.